Is there a Role for Angiotensin II in COVID-19 Patients with Shock?
This resource details how angiotensin II can used for COVID-19 patients with shock.
This is SCCM curated COVID-19 microlearning content.
Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019–Induced Vasodilatory Shock: A Retrospective Matched Cohort Study
From Critical Care Explorations. In this study, the authors found that angiotensin-II treatment for coronavirus disease 2019–induced distributive shock was associated with rapid improvement in multiple physiologic indices and that angiotensin-II in coronavirus disease 2019–induced shock warrants further study.
Diagnosis and Management of Shock
Point of Care (PoC) Refresher Training